Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

25 results
Display

Effects of Angiotensin II on ZO-1 in Glomerular Epithelial Cells

Koo HH, Ha TS

  • KMID: 2307207
  • Korean J Nephrol.
  • 2007 Sep;26(5):516-525.
PURPOSE: Angiotensin II plays a potent role in renal injury not only by vasoconstrictive effects but also by biochemical effects. We investigated the effect of angiotensin II on ZO-1 (zonular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Severe Hyponatremia Associated with the Use of Angiotensin II Receptor Blocker/thiazide Combinations

Kim DR, Cho JH, Jang WS, Kim JS, Jeong KH, Lee TW, Ihm CG

There are several widely used combinations of angiotensin II receptor blocker (ARB)/thiazide. The complimentary mechanism of action for such anti-hypertensive therapies is that, while ARB inhibits the vasoconstricting and aldosterone-secreting...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Add-on Therapy of Potassium-exchange Resin for Hrkalemia in Chronic Kidney Disease Patients on Renin-angiotensin System Blockers

Yi JH, Yun YW, Noh U, Kim EY, Park JI, Han SW, Kim HJ

  • KMID: 2307209
  • Korean J Nephrol.
  • 2007 Sep;26(5):534-540.
PURPOSE: This prospective study aimed to evaluate the safety and efficacy of potassium-exchange resin (PER, Kalimate(R) or Argamate(R)) for managing hyperkalemia induced by Renin-Angiotensin System (RAS) blockers in chronic kidney...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acute Renal Failure with Pulmonary Edema Induced by the Treatment of Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in a Patient with Congenital Solitary Kidney

Baek DH, Kim KJ, Hong SC, Kang SH, Song HE, Kim HI, Kim SH, Oh HJ, Kang HW, Kim SW, Yu MA, Ryu DR, Choi KB, Kang DH

Blockers of renin-angiotensin system(RAS) including ACE inhibitor or ARB are one of the most frequently prescribed medications for the treatment of hypertension, heart failure and proteinuria. One of the major...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway

Kim I, Park CS, Lee HY

BACKGROUND AND OBJECTIVES: Angiotensin II (Ang II) has been suggested to accelerate vascular senescence, however the molecular mechanism(s) remain unknown. METHODS: We cultured human coronary artery smooth muscle cells (hCSMCs) and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Blood Pressure Control Rate and Changes in Medication Patterns after Antihypertensive Monotherapy Choice

Lee S

  • KMID: 1966881
  • Korean J Med.
  • 2011 Feb;80(2):193-202.
BACKGROUND/AIMS: This study was performed to observe blood pressure (BP) control rate with changes in patterns of antihypertensive drugs in patients with hypertension. METHODS: The subjects were first prescribed antihypertensive drugs...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Angiotensin II Modulates p130Cas of Podocytes by the Suppression of AMP-Activated Protein Kinase

Ha TS, Park HY, Seong SB, Ahn HY

Angiotensin II (Ang II) induces the pathological process of vascular structures, including renal glomeruli by hemodynamic and nonhemodynamic direct effects. In kidneys, Ang II plays an important role in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Patients Following Ablation of Atrial Fibrillation

Park JH, Oh YS, Kim JH, Chung WB, Oh SS, Lee DH, Choi YS, Shin WS, Park CS, Youn HJ, Chung WS, Lee MY, Seung KB, Rho TH, Kim JH, Hong SJ

BACKGROUND AND OBJECTIVES: It is known that angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockers (ACEIs and ARBs, respectively) are effective in preventing atrial fibrillation (AF) in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Telmisartan on Endothelial Function and Arterial Stiffness in Patients With Essential Hypertension

Jung AD, Kim W, Park SH, Park JS, Cho SC, Hong SB, Hwang SH, Kim W

BACKGROUND AND OBJECTIVES: Several studies have shown that angiotensin II receptor blockers (ARBs) improve endothelial function and arterial stiffness. Telmisartan is a highly selective ARB that activates peroxisome proliferator-activated receptor...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Retrospective Comparisons about Effects of Angiotensin II Receptor Blocker and/or Steroid on Proteinuria Reduction and Renal Protection in IgA Nephropathy Patients with Proteinuria less than 1 g/g

Hwang SJ, Choi SY, Cho SY, Park JY, Jung KH, Moon JY, Lee SH, Lee TW, Ihm CG

  • KMID: 2307166
  • Korean J Nephrol.
  • 2009 Nov;28(6):579-587.
PURPOSE: It remains controversial how to treat the IgA nephropathy (IgAN) patients with proteinuria
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Change of Selection to Antihypertensive Drugs in Hypertensive Patients with Diabetes Mellitus: In Pohang . Gyeongju Primary Care Research Network

Yun ZY, Lee DW, Jung HS, Park KH, Lee SH, Park JJ, Kim DI, Ki JM, Cho KR, Song JS, Choi S, U CH, Jung TH, Jung SH, Kim SW, Kim I

BACKGROUND: Angiotensin converting enzyme inhibitors (ACEIs) or Angiotensin II type 1 receptor blockers (ARBs) are compelling indication drugs for hypertensive patients with diabetes mellitus. But prescription rate in 2005 year...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats

Jin K, Kim TH, Kim YH, Kim YW

BACKGROUND/AIMS: Magnesium (Mg) is an essential element for vascular function and blood pressure regulation. Several studies have demonstrated that Mg concentration is inversely associated with blood pressure, and that Mg...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of RAAS Inhibition on the Incidence of Cancer and Cancer Mortality in Patients with Glomerulonephritis

Chin HJ, Oh SW, Goo HS, Oh J, Noh JW, Cho JT, Na KY, Kim S, Chae DW, Members of the PREMIER Group

Angiotensin II type 1 receptor blocker (ARB), which is frequently prescribed in patients with glomerulonephritis (GN), is suggested to increase the risk of cancer. We registered 3,288 patients with renal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension

Lee HY, Kim CH, Song JK, Chae SC, Jeong MH, Kim DS, Oh BH

BACKGROUND/AIMS: Fimasartan is an angiotensin type 1 receptor blocker (ARB) which has comparable efficacy and tolerability with other ARBs. The aim of this study was to evaluate 24-hour blood pressure...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction

Lee JH, Bae MH, Yang DH, Park HS, Cho Y, Lee WK, Jeong MH, Kim YJ, Cho MC, Kim CJ, Chae SC, Korea Acute Myocardial Infarction Registry Investigators

BACKGROUND/AIMS: Angiotensin II type 1 receptor blockers (ARBs) have not been adequately evaluated in patients without left ventricular (LV) dysfunction or heart failure after acute myocardial infarction (AMI). METHODS: Between November...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography

Goo JJ, Kim JJ, Kang JH, Kim KN, Byun KS, Kim MK, Kim TI

BACKGROUND/AIMS: With the increasing incidence of cardiovascular disease, angiocardiography using contrast-enhancing media has become an essential diagnostic and therapeutic tool, despite the risk of contrast-medium-induced acute kidney injury (CIAKI). CIAKI...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Behcet's Disease Complicated by IgA Nephropathy

Ryu YS, Jeon CH, Jin SY

Behcet's disease (BD) is a rare, multisystemic disorder characterized by vasculitis. Although renal involvement rarely coexists with BD, several types of renal involvements have been reported: amyloidosis, glomerulonephritis and vascular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of Cardiac Function by Transthoracic Echocardiography in Subjects with ST-Segment Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention according to Valsartan Dose: The Valsartan One Center Trial

Kim SS, Jeon HK, Cho GM, Lee JH, Kim SJ, Park MY, Lee SJ, Shim BJ, Lee DH, Shin WS, Lee JM, Youn HJ

BACKGROUND: The aim of this study was to evaluate the mid-term changes in cardiac function by transthoracic echocardiogram (TTE) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Angiotensin III increases monocyte chemoattractant protein-1 expression in cultured human proximal tubular epithelial cells

Kim HW, Kim YO, Yoon SA, Han JS, Chun HB, Kim YS

BACKGROUND/AIMS: We investigated whether angiotensin III (Ang III) is involved in monocyte recruitment through regulation of the chemokine monocyte chemoattractant protein-1 (MCP-1) in cultured human proximal tubular epithelial cells (HK-2...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inhibitory Effect of Angiotensin Blockade on Hepatic Fibrosis in Common Bile Duct-ligated Rats

Park DH, Baik SK, Choi YH, Kim MY, Rhim DW, Kim JW, Kwon SO, Cho MY, Kim CH, Ahn SC

  • KMID: 760706
  • Korean J Hepatol.
  • 2007 Mar;13(1):61-69.
BACKGROUNDS AND AIMS: Angiotensin receptors are found on hepatic stellate cells, which participate in hepatic fibrosis. Therefore, it is presumed that angiotensin has a role in hepatic fibrosis. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr